Gilgamesh Pharmaceuticals
Phase 1We develop novel medicines that harness the therapeutic promise of psychedelics to revolutionize the treatment of mental illness
Founded
2021
Focus
Small MoleculesPsychedelics
About
We develop novel medicines that harness the therapeutic promise of psychedelics to revolutionize the treatment of mental illness
Funding History
2Total raised: $110M
Series B$71MBVF PartnersDec 15, 2023
Series A$39MAtlas VentureMay 15, 2022
Company Info
TypePrivate
Founded2021
LocationNew York, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile